BCL2 and central nervous system cancer: Levels of pro-apoptotic proteins (including Bad and cleaved-caspase-9) were increased, while the expressions of anti-apoptotic markers(e.g., MMP-9, MMP-2, and Bcl-2) were decreased in PQR309-treated glioma models [22].